Literature DB >> 10858361

Modulation of erm methyltransferase activity by peptides derived from phage display.

R B Giannattasio1, B Weisblum.   

Abstract

Combinatorial peptide display on phage M13 protein pIII was used to discover peptide sequences that selectively bind to ErmC' methyltransferase from Bacillus subtilis. One peptide, Ac-LSGVIAT-NH(2), inhibited methylation in vitro with a 50% inhibitory concentration of 20 microM. Interestingly, the set of six peptides which inhibited ErmC' stimulated ErmSF, a homologous methyltransferase from Streptomyces fradiae. Thus, Ac-LSGVIAT-NH(2) may not act directly at the catalytic center of ErmC', but may modulate its activity by binding at a structurally unrelated, but functionally linked, site.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858361      PMCID: PMC89992          DOI: 10.1128/AAC.44.7.1961-1963.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Novel inhibitors of Erm methyltransferases from NMR and parallel synthesis.

Authors:  P J Hajduk; J Dinges; J M Schkeryantz; D Janowick; M Kaminski; M Tufano; D J Augeri; A Petros; V Nienaber; P Zhong; R Hammond; M Coen; B Beutel; L Katz; S W Fesik
Journal:  J Med Chem       Date:  1999-09-23       Impact factor: 7.446

2.  Crystal structure of ErmC', an rRNA methyltransferase which mediates antibiotic resistance in bacteria.

Authors:  D E Bussiere; S W Muchmore; C G Dealwis; G Schluckebier; V L Nienaber; R P Edalji; K A Walter; U S Ladror; T F Holzman; C Abad-Zapatero
Journal:  Biochemistry       Date:  1998-05-19       Impact factor: 3.162

3.  Solution structure of an rRNA methyltransferase (ErmAM) that confers macrolide-lincosamide-streptogramin antibiotic resistance.

Authors:  L Yu; A M Petros; A Schnuchel; P Zhong; J M Severin; K Walter; T F Holzman; S W Fesik
Journal:  Nat Struct Biol       Date:  1997-06

Review 4.  Erythromycin resistance by ribosome modification.

Authors:  B Weisblum
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

Review 5.  Insights into erythromycin action from studies of its activity as inducer of resistance.

Authors:  B Weisblum
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

6.  Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase.

Authors:  J Clancy; B J Schmieder; J W Petitpas; M Manousos; J A Williams; J A Faiella; A E Girard; P R McGuirk
Journal:  J Antibiot (Tokyo)       Date:  1995-11       Impact factor: 2.649

7.  The 2.2 A structure of the rRNA methyltransferase ErmC' and its complexes with cofactor and cofactor analogs: implications for the reaction mechanism.

Authors:  G Schluckebier; P Zhong; K D Stewart; T J Kavanaugh; C Abad-Zapatero
Journal:  J Mol Biol       Date:  1999-06-04       Impact factor: 5.469

8.  23S rRNA domain V, a fragment that can be specifically methylated in vitro by the ErmSF (TlrA) methyltransferase.

Authors:  D Kovalic; R B Giannattasio; H J Jin; B Weisblum
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

  8 in total
  2 in total

1.  Identification of essential residues in the Erm(B) rRNA methyltransferase of Clostridium perfringens.

Authors:  Kylie A Farrow; Dena Lyras; Galina Polekhina; Katerina Koutsis; Michael W Parker; Julian I Rood
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Intracellular expression of Peptide fusions for demonstration of protein essentiality in bacteria.

Authors:  R Edward Benson; Elizabeth B Gottlin; Dale J Christensen; Paul T Hamilton
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.